Pharmaceutical Commerce - April 2023 Issue (PDF)

Mitigating Drug Shortages

The rationale behind transforming case management in healthcare.

April 12th 2024

FDA Approves Takeda’s Subcutaneous Form of Entyvio as a Maintenance Therapy in Adults with Moderately to Severe Crohn Disease

Allen Jacques explains the history behind medications’ lack of supply, while offering ways to help alleviate their impact.

A Further Examination of Pharmacy Benefit Managers

Approval was based on positive data from Takeda’s Phase III VISIBLE 2 study, which displayed long-term clinical remission in approximately half of patients with Crohn disease receiving Entyvio.

March 29th 2024

LogiPharma Europe 2024: Properly Applying Diversity, Equity, and Inclusion Initiatives Within the Life Sciences Supply Chain

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

Genentech Shares Promising Results from Phase III OCARINA II Study of Ocrevus for Elapsing, Primary Progressive Multiple Sclerosis

Panel discussion addresses how DE&I can successfully tackle systemic biases and more.

April 18th 2024

From Toggling Tediously Between Systems to Achieving Whole-Person Care

Data displayed rapid and sustained B-cell depletion, with 97.2% of study patients with relapsing and primary progressive multiple sclerosis experiencing no relapses.

Related Content

April 22nd 2024

Mitigating Drug Shortages

The rationale behind transforming case management in healthcare.

April 12th 2024

FDA Approves Takeda’s Subcutaneous Form of Entyvio as a Maintenance Therapy in Adults with Moderately to Severe Crohn Disease

Allen Jacques explains the history behind medications’ lack of supply, while offering ways to help alleviate their impact.

A Further Examination of Pharmacy Benefit Managers

Approval was based on positive data from Takeda’s Phase III VISIBLE 2 study, which displayed long-term clinical remission in approximately half of patients with Crohn disease receiving Entyvio.

March 29th 2024

LogiPharma Europe 2024: Properly Applying Diversity, Equity, and Inclusion Initiatives Within the Life Sciences Supply Chain

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

Genentech Shares Promising Results from Phase III OCARINA II Study of Ocrevus for Elapsing, Primary Progressive Multiple Sclerosis

Panel discussion addresses how DE&I can successfully tackle systemic biases and more.

April 18th 2024